*  Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis - Full Text View - ClinicalTrials.gov
Antibiotics, Antitubercular. Antitubercular Agents. Anti-Bacterial Agents. Anti-Infective Agents. Leprostatic Agents. Nucleic ...
  https://clinicaltrials.gov/show/NCT00376012
*  Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment - Full Text...
Antitubercular Agents. Reverse Transcriptase Inhibitors. Nucleic Acid Synthesis Inhibitors. Enzyme Inhibitors. Molecular ... Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Anti-HIV Agents. Cytochrome P-450 CYP2C9 Inhibitors. ... Description of Agent or Intervention:. The study intervention is to start patients with HIV and tuberculosis on anti-retroviral ...
  https://clinicaltrials.gov/show/NCT00332306?order=209
*  Immune Activation and Drug Absorption in HIV-Infected Patients - Full Text View - ClinicalTrials.gov
Antibiotics, Antitubercular. Antitubercular Agents. Anti-Bacterial Agents. Anti-Infective Agents. Leprostatic Agents. Nucleic ... Antimicrob Agents Chemother. 2004 Nov;48(11):4473-5. Chigutsa E, Visser ME, Swart EC, Denti P, Pushpakom S, Egan D, Holford NH ... Antimicrob Agents Chemother. 2011 Sep;55(9):4122-7. doi: 10.1128/AAC.01833-10. Epub 2011 Jun 27. ... Receipt of any investigational therapy, chemotherapy, or immune modulatory agents within 42 days prior to study entry. ...
  https://clinicaltrials.gov/show/NCT01845298?order=683
*  Synthesis and Antitubercular Activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3...
Among all the tested compounds in the series, compounds 7 and 11 emerged as promising antitubercular agents at 16 μg/mL against ... Synthesis and Antitubercular Activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3, ... They were evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv, multidrug resistance ...
  http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12065/full?globalMessage=0
*  Review of Evidence for Measuring Drug Concentrations of First-Line Antitubercular Agents in Adults
... ... Although TDM of first-line antitubercular drugs is used during the treatment of tuberculosis, the extent of any benefit ... This review summarizes the available literature describing TDM of first-line treatment agents in patients with tuberculosis and ... literature review was conducted for articles describing drug concentration and TDM outcomes for first-line tuberculosis agents ...
  http://qspace.qu.edu.qa/handle/10576/4153
*  Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis - Full Text View -...
Reproductive Control Agents. Physiological Effects of Drugs. Nucleic Acid Synthesis Inhibitors. Antibiotics, Antitubercular. ... Antineoplastic Agents. Contraceptives, Oral, Combined. Contraceptives, Oral. Contraceptive Agents, Female. Contraceptive Agents ... Anti-Bacterial Agents. Anti-Infective Agents. Topoisomerase II Inhibitors. Topoisomerase Inhibitors. Enzyme Inhibitors. ... The long term goal of this study is to identify the factors behind poor lesion penetration, so that new agents can be optimized ...
  https://clinicaltrials.gov/ct2/show/NCT00816426?term=NIAID&recr=Open&no_unk=Y&cond=tuberculosis&rank=6
*  Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis - Full Text View -...
Antitubercular Agents. Reverse Transcriptase Inhibitors. Nucleic Acid Synthesis Inhibitors. Enzyme Inhibitors. Molecular ... Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Cytochrome P-450 CYP2C9 Inhibitors. Cytochrome P-450 Enzyme ...
  https://clinicaltrials.gov/show/NCT01315301?order=125
*  Hybrid Docking-QSAR Studies of 1, 4-dihydropyridine-3, 5-Dicarboxamides as Potential Antitubercular Agents | BenthamScience
Hybrid Docking-QSAR Studies of 1, 4-dihydropyridine-3, 5-Dicarboxamides as Potential Antitubercular Agents. Author(s): Yasaman ... 1, 4-dihydropyridines are multi-target ligands that recently are recognized as anti-tubercular agents. ... Title:Hybrid Docking-QSAR Studies of 1, 4-dihydropyridine-3, 5-Dicarboxamides as Potential Antitubercular Agents ... 1, 4-dihydropyridines are multi-target ligands that recently are recognized as anti-tubercular agents. ...
  http://www.eurekaselect.com/node/151912/article/hybrid-docking-qsar-studies-of-1-4-dihydropyridine-3-5-dicarboxamides-as-potential-antitubercular-agents
*  Influence of genetic variants on toxicity to anti-tubercular agents : a systematic review and meta-analysis (protocol)
... ... Influence of genetic variants on toxicity to anti-tubercular agents : a systematic review and meta-analysis (protocol) ' ...
  https://research-repository.st-andrews.ac.uk/handle/10023/11197
*  Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents. -...
... seventeen novel quinoline-based carboxylic hydrazides were designed as potential anti-tubercular agents using molecular ... Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.. *. ... In this study, seventeen novel quinoline-based carboxylic hydrazides were designed as potential anti-tubercular agents using ... synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.}, author={Subhash ...
  https://www.semanticscholar.org/paper/Design-synthesis-and-biological-evaluation-of-nove-Chander-Ashok/641131ffc94b85f5def9efd3ef88f988fff7b6db
*  Drug-induced ocular side effects (Book, 2001) [WorldCat.org]
Antifungal agents. Antileprosy agents. Antimalarial agents. Antiprotozoal agents. Antitubercular agents --. 2. Agents affecting ... Antifungal agents. Antileprosy agents. Antimalarial agents. Antiprotozoal agents. Antitubercular agents -- 2. Agents affecting ... Oxytocic agents --. 9. Homeostatic and nutrient agents: Agents used to treat hyperglycemia. Vitamins --. 10. Agents used to ... Oxytocic agents -- 9. Homeostatic and nutrient agents: Agents used to treat hyperglycemia. Vitamins -- 10. Agents used to treat ...
  http://www.worldcat.org/title/drug-induced-ocular-side-effects/oclc/44129071
*  EARNEST Rifabutin Pharmacokinetics (PK) Substudy - Full Text View - ClinicalTrials.gov
Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Cytochrome P-450 CYP3A Inhibitors. Cytochrome ...
  https://clinicaltrials.gov/show/NCT01663168?order=209
*  TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB - Full Text View - ClinicalTrials.gov
Antitubercular Agents. Anti-Bacterial Agents. Anti-Infective Agents. Fatty Acid Synthesis Inhibitors. Hypolipidemic Agents. ...
  https://clinicaltrials.gov/show/NCT00023348?order=30
*  Antibiotic Treatment Trial for the PANDAS/PANS Phenotype - Full Text View - ClinicalTrials.gov
Anti-Bacterial Agents. Antibiotics, Antitubercular. Anti-Infective Agents. Antitubercular Agents. To Top ... Int J Antimicrob Agents. 2001 Jun;17(6):439-42. Review. Brook I. A pooled comparison of cefdinir and penicillin in the ... Patients with tics respond well to a variety of evidence based pharmacologic agents and behavioral treatments if needed due to ... Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive- ...
  https://clinicaltrials.gov/ct2/show/study/NCT01617083?term=lyme&rank=48&show_desc=Y
*  Tuberculosis Prevention for HIV Infected Adults - Full Text View - ClinicalTrials.gov
Antibiotics, Antitubercular. Antitubercular Agents. Anti-Bacterial Agents. Anti-Infective Agents. Leprostatic Agents. Nucleic ...
  https://clinicaltrials.gov/show/NCT00057122?order=29
*  TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine - Full Text View -...
Antitubercular Agents. Anti-Bacterial Agents. Anti-Infective Agents. Fatty Acid Synthesis Inhibitors. Hypolipidemic Agents. ... Lipid Regulating Agents. Antibiotics, Antitubercular. Leprostatic Agents. Nucleic Acid Synthesis Inhibitors. Enzyme Inhibitors ...
  https://clinicaltrials.gov/show/NCT00023387?order=165
*  Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) - Full Text View -...
Antitubercular Agents. HIV Protease Inhibitors. Protease Inhibitors. Enzyme Inhibitors. Molecular Mechanisms of Pharmacological ... Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. Cytochrome P-450 CYP3A Inhibitors. Cytochrome ... Antimicrob Agents Chemother. 2016 Mar 25;60(4):2171-9. doi: 10.1128/AAC.02600-15. Print 2016 Apr. ...
  https://clinicaltrials.gov/show/NCT01637558?order=161
*  Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis - Full Text View - ClinicalTrials.gov
Antineoplastic Agents. Antibiotics, Antitubercular. Antitubercular Agents. Anti-Bacterial Agents. Anti-Infective Agents. Enzyme ... Mycophenolate mofetil (CellCept) is used as an immunosuppressive agent in allogenic transplants in pediatric patients and is ... mount an immune response in cln3-knockout mice is supportive of a strategy for treating JNCL with an immuno-suppressive agent. ...
  https://clinicaltrials.gov/ct2/show/NCT01399047?cond=%22Ceroid+lipofuscinosis+neuronal+3%22&rank=1
*  Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease...
Anti-Infective Agents. Cytochrome P-450 CYP3A Inhibitors. Cytochrome P-450 Enzyme Inhibitors. Antibiotics, Antitubercular. ... Anti-HIV Agents. Anti-Retroviral Agents. Antiviral Agents. ...
  https://clinicaltrials.gov/show/NCT00038519?order=312
*  A Study of a Combination of Four Drugs in Patients With Recent HIV Infection - Full Text View - ClinicalTrials.gov
Anti-HIV Agents. HIV Protease Inhibitors. Protease Inhibitors. Antibiotics, Antitubercular. Antitubercular Agents. Anti- ... Anti-Retroviral Agents. Antiviral Agents. Anti-Infective Agents. ... Foscarnet or therapy with other agents with documented in vitro ... Therapy with immunomodulating agents such as systemic corticosteroids, interleukins, thalidomide, anti-cytokine agents or ... interferons, cytotoxic chemotherapeutic agents, or anti-oxidants within 30 days of study entry. ...
  https://clinicaltrials.gov/show/NCT00002233?order=107